VaProductName^OiName^PropInactivationDate^SynonymMultiple^WitnessRequired^PatientSpecificLabel^ProtectFromLight^DoNotHandlePregnant^FollowUpTime^HazardToDispose^HazardToHandle^HazardToPatient^LongTermOutOfStock^LowSafetyMargin^NonRenewable^LabMonitorMark^Formulary^NcpdpDispenseUnit^NcpdpQtyMultiplier^ApprovedForSplitting^DoNotMail^ArWsAmisCategory^ArWsAmisConvertNumber^DawCode^DayOrDoseLimit^DispDaysSupplyLimit^DispLimitForOrder^DispLimitForSchedule^DispOverride^DispOverrideReason^DispQtyLimitDose^DispQtyLimitTime^DispQtyOverride^DispQtyOverrideReason^DispUnitPerOrderUnit^FsnNsn^HighRiskMed^HighRiskFollowup^HighRiskFollowupTime^InpatMedExpOrdMaxTime^InpatMedExpOrdMinTime^MaxDispenseLimit^MaxDosePerDay^RxMessage^MonitorMaxDays^OrderUnit^DispOverrideReasonBy^QtyDispMessage^RequestRejectReason^RejectReasonText^SecondaryVaDrugClass^TotalDispenseQty^UnitDoseSchedule^UnitDoseScheduleType^Refrigeration^DefaultMailService^RecallLevel^TallmanLettering^DeaSchedule^MonitorRoutine^NatDrugText^NumberOfDoses
ACETAMINOPHEN 523MG TAB^DIGOXIN TAB^20110912^Name1::12345-9999-44::Vendor1::VSN1::D-DRUG ACCOUNTABILITY::BX::11.11::22.22::33.33||Name2::12345-9999-45::Vendor2::VSN2::1-QUICK CODE::PT::17.01::17.02::17.03^Y^Y^Y^Y^Y^Y^Y^^N^Y^Y^Y^Y^FORMULARY WITH RESTRICTIONS^ML-MILLILITERS^12^Y^Y^3-BLOOD PRODUCT^6000^7-SUBSTITUTION NOT ALLOWED-BRAND DRUG MANDATED BY LAW^45D^255^There is a high limit for this order^There is a low limit for this schedule^You should override this^This is the override^800^85^Quantity Override is entered^The reason for the override^222.3344^FSN100/NSN200^Y^Y^EVERY 16 Minutes^400 Days^20 Minutes^372.90879^25^This is the Rx--Message^899^BX^Todd Schippers^Dispense This Quantity^INAPPROPRIATE_REQUEST^Reject this item^INVESTIGATIONAL GENE THERAPY::IN950||LINCOMYCINS::AM350^Total Dispensy Quantity^3 Hours^P - PRN^Y^Federal Express^2-CLASS 2^tallmanLETTERing^6-Legend Item^RN37B^RESTRICTED TO NEUROLOGY^172
